Hans Melo ^UDM

Hans Melo, as Co-Founder and CEO of Menten AI, leads the company's efforts in designing new protein drugs and enzymes using quantum computers and machine learning. Menten AI addresses the challenge of finding the right protein shapes for drugs and biocatalysts. Hans' leadership is essential in Menten AI’s quest to pioneer protein design through advanced computational methods.